{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"JAK Inhibition and the Future of HS Treatment","description":"The management of hidradenitis suppurativa (HS) is evolving, but many patients still face significant hurdles in achieving optimal outcomes with current therapies. In this episode, &quot;JAK Inhibition and the Future of HS Treatment,&quot; expert dermatologists, Hadar Lev-Tov, MD, and Jennifer L. Hsiao, MD discuss:   Increasing Awareness: Debunking common myths and misconceptions about HS.   Building Trust: Strategies for overcoming diagnostic delays and insufficient management.   Comprehensive Care: Adopting a holistic approach, including addressing common comorbidities.   The Road Ahead: Exploring the future of the HS treatment landscape, including JAK inhibition.   ","author_name":"DermDocs","author_url":"http:\/\/dermdocs.libsyn.com\/website","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/39293520\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/196243955"}